Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

72.77
Delayed Data
As of Feb 11
 +0.39 / +0.54%
Today’s Change
57.71
Today|||52-Week Range
110.68
-19.40%
Year-to-Date

Today’s Trading

Previous close72.38
Today’s open70.84
Day’s range69.14 - 73.22
Volume611,509
Average volume (3 months)688,976
Market cap$3.1B
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)+1,372.22%
Earnings growth (this year)-69.94%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+25.41%
P/E ratio25.8
Price/Sales13.32
Price/Book10.26

Competitors

 Today’s
change
Today’s
% change
MRMindray Medical Inte...-0.01-0.04%
GMEDGlobus Medical Inc-0.36-1.58%
WSTWest Pharmaceutical ...-1.02-1.83%
IARTIntegra LifeSciences...-0.46-0.82%
Data as of 02/11/2016

Financials

Next reporting dateApril 28, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$230.3M
Annual profit (last year)$113.7M
Net profit margin49.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers